Revision history of "Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons" (Q43120316)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 September 2024

25 September 2023

18 March 2022

14 April 2021

18 July 2020

17 July 2020

7 June 2020

31 August 2019

18 May 2019

1 January 2019

30 December 2018

29 October 2018

15 August 2018

26 May 2018

14 November 2017